Alexion shoots down 'proactive' sale demand from activist investor

Alexion shoots down 'proactive' sale demand from activist investor

Source: 
Fierce Pharma
snippet: 

Alexion has withstood its fair share of gales in recent years after a wholesale shakeup at the top and a shift toward an M&A-focused strategy underway. Now, despite one activist investor's call for a "proactive" sale, Alexion's board has decided to stay the course.